Valeant CEO Vows to Recoup Lost Market Share On
Post# of 193
On his official Twitter account, which Valeant Pharmaceuticals opened recently, CEO J. Michael Pearson vowed to recoup Valeant's lost market share.
He invited investors to join him on Dec. 16 investor day and slammed "activist journalists and short-sellers" pointing that VRX share prices have gained 37% "from Nov. 18 lows and [will continue] rising."
Mr Pearson added "We've been working tirelessly behind the closed doors to defend $VRX and bring growth to our investors. Our results speak for themselves."
Mr Pearson announced "Exciting new product line, just the tip of the iceberg. More good stuff on Dec 16 (8:00 am - 12:30 pm ET)."
He pointed that "Handful of short-sellers account for 99% of misleading, inaccurate and/or outright false information circulating online and in media."
"I've repeatedly urged SEC to investigate several short-sellers involved in $VRX stock manipulation. I urge SEC again to show leadership."
Mr Pearson also thanked "all our supporters for believing in us. We'll never betray your trust. $VRX investors are our #1 priority."
Source: J. Michael Pearson (Twitter)